 |
||||
| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
*Laboratory and Unit of Nephrology and Laboratory of Molecular Genetics, Istituto Giannina Gaslini, Genoa, Italy; and Istituto di Medicina Clinica, University of Trieste, Trieste, Italy.
Correspondence to Dr. Gian Marco Ghiggeri, Laboratory and Unit of Nephrology, G. Gaslini Institute, Largo G. Gaslini 5, 16148, Genoa, Italy. Phone: +39-010-380742; Fax: +39-010-395214; E-mail: labnefro{at}ospedale-gaslini.ge.it
ABSTRACT. Podocin mutations (NPHS2 gene) are responsible for the autosomal recessive form of steroid-resistant nephrotic syndrome. As a result of a screening for these gene alterations in a cohort of Italian patients with nonfamilial nephrotic syndrome and histologic focal segmental glomerulosclerosis (FSGS), nine patients with NPHS2 gene homozygous or composite heterozygous mutations were found. In addition to the previously described defects, two novel mutations at exon 4 were identified (frameshift, L169P); four single nucleotide polymorphisms (SNPs) and one dinucleotide repeat were also identified. On the basis of haplotype analysis, a founder effect was suggested for the 419delG mutation, the most frequently observed in the patients studied. Patients carrying NPHS2 mutations and without a family history of nephrotic syndrome were indistinguishable from those with idiopathic FSGS on the basis of the clinical phenotype. Two of the nine patients had normal renal function at 3 and 10 yr of age, despite the presence of the nephrotic syndrome. The other seven had reached end-stage renal failure at a mean age of 9.6 yr (range, 4 to 17 yr) and had received renal allografts. In those presenting with end-stage renal failure, the clinical and laboratory features both before and after transplantation were similar, including the age at onset, the amount of proteinuria, and the absence of any response to steroids and other immunosuppressants. Finally, two children presented recurrence of mild proteinuria after transplantation, which promptly remitted after plasmapheresis combined with cyclophosphamide. These data demonstrate that podocin mutations in nonfamilial cases of steroid-resistant nephrotic syndrome are frequent and may be due in one case to a founder effect. The pretransplantation and posttransplantation outcomes in the group of patients with mutations of the podocin gene are similar to classical idiopathic FSGS, including the possibility of recurrence of proteinuria that is mild and responsive to plasmapheresis. These observations support a role of molecular screening of the podocin gene in patients with nephrotic syndrome before immunosuppressive treatment is started.
This article has been cited by other articles:
 |
|
 |
|
  M. Gigante, P. Pontrelli, E. Montemurno, L. Roca, F. Aucella, R. Penza, G. Caridi, E. Ranieri, G. M. Ghiggeri, and L. Gesualdo CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS) Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1858 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Caridi, M. Gigante, P. Ravani, A. Trivelli, G. Barbano, F. Scolari, M. Dagnino, L. Murer, C. Murtas, A. Edefonti, et al. Clinical Features and Long-Term Outcome of Nephrotic Syndrome Associated with Heterozygous NPHS1 and NPHS2 Mutations Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1065 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Ahmed and C. F. Wong Rituximab and nephrotic syndrome: a new therapeutic hope? Nephrol. Dial. Transplant., January 1, 2008; 23(1): 11 - 17. [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. McKenzie, S. L. Hendrickson, W. A. Briggs, R. A. Dart, S. M. Korbet, M. H. Mokrzycki, P. L. Kimmel, T. S. Ahuja, J. S. Berns, E. E. Simon, et al. NPHS2 Variation in Sporadic Focal Segmental Glomerulosclerosis J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2987 - 2995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Caridi, M. Dagnino, A. Carrea, L. Massella, A. Amore, F. Emma, R. Coppo, F. Perfumo, and G. M. Ghiggeri Lack of cardiac anomalies in children with NPHS2 mutations Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1477 - 1479. [Full Text] [PDF]
|
|
|
|
|
|
L. Musante, G. Candiano, A. Petretto, M. Bruschi, N. Dimasi, G. Caridi, B. Pavone, P. Del Boccio, M. Galliano, A. Urbani, et al. Active Focal Segmental Glomerulosclerosis Is Associated with Massive Oxidation of Plasma Albumin J. Am. Soc. Nephrol., March 1, 2007; 18(3): 799 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. He, A. Zahirieh, Y. Mei, B. Lee, S. Senthilnathan, B. Wong, B. Mucha, F. Hildebrandt, D. E. Cole, D. Cattran, et al. Recessive NPHS2 (Podocin) Mutations Are Rare in Adult-Onset Idiopathic Focal Segmental Glomerulosclerosis Clin. J. Am. Soc. Nephrol., January 1, 2007; 2(1): 31 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kitamura, H. Tsukaguchi, K. Iijima, J. Araki, M. Hattori, M. Ikeda, M. Honda, K. Nozu, H. Nakazato, N. Yoshikawa, et al. Genetics and clinical features of 15 Asian families with steroid-resistant nephrotic syndrome Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3133 - 3138. [Full Text] [PDF]
|
|
|
|
|
|
Z. Yu, J. Ding, J. Huang, Y. Yao, H. Xiao, J. Zhang, J. Liu, and J. Yang Mutations in NPHS2 in sporadic steroid-resistant nephrotic syndrome in Chinese children Nephrol. Dial. Transplant., May 1, 2005; 20(5): 902 - 908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Carraro, C. Zennaro, M. Artero, G. Candiano, G. M. Ghiggeri, L. Musante, C. Sirch, M. Bruschi, and L. Faccini The effect of proteinase inhibitors on glomerular albumin permeability induced in vitro by serum from patients with idiopathic focal segmental glomerulosclerosis Nephrol. Dial. Transplant., August 1, 2004; 19(8): 1969 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. L. Liu, S. C. Done, K. Yan, P. Kilpelainen, T. Pikkarainen, and K. Tryggvason Defective Trafficking of Nephrin Missense Mutants Rescued by a Chemical Chaperone J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1731 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. Li, Y. Du, C.-X. Li, H. Guo, J. C.K. Leung, M. F. Lam, N. Yang, F. Huang, Y. Chen, J.-Q. Fang, et al. Family-Based Association Study Showing that Immunoglobulin A Nephropathy Is Associated with the Polymorphisms 2093C and 2180T in the 3' Untranslated Region of the Megsin Gene J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1739 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Ghiggeri, M. Carraro, and F. Vincenti Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1036 - 1040. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Ruf, A. Lichtenberger, S. M. Karle, J. P. Haas, F. E. Anacleto, M. Schultheiss, I. Zalewski, A. Imm, E.-M. Ruf, B. Mucha, et al. Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome J. Am. Soc. Nephrol., March 1, 2004; 15(3): 722 - 732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Niaudet Podocin and Nephrotic Syndrome: Implications for the Clinician J. Am. Soc. Nephrol., March 1, 2004; 15(3): 832 - 834. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Roselli, L. Heidet, M. Sich, A. Henger, M. Kretzler, M.-C. Gubler, and C. Antignac Early Glomerular Filtration Defect and Severe Renal Disease in Podocin-Deficient Mice Mol. Cell. Biol., January 15, 2004; 24(2): 550 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-C. Gubler Podocyte Differentiation and Hereditary Proteinuria/Nephrotic Syndromes J. Am. Soc. Nephrol., June 1, 2003; 14(90001): S22 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Caridi, R. Bertelli, M. Di Duca, M. Dagnino, F. Emma, A. Onetti Muda, F. Scolari, N. Miglietti, G. Mazzucco, L. Murer, et al. Broadening the Spectrum of Diseases Related to Podocin Mutations J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1278 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Pollak Inherited Podocytopathies: FSGS and Nephrotic Syndrome from a Genetic Viewpoint J. Am. Soc. Nephrol., December 1, 2002; 13(12): 3016 - 3023. [Full Text] [PDF]
|
|
|
|
|
|
M. Carraro, G. Caridi, M. Bruschi, M. Artero, R. Bertelli, C. Zennaro, L. Musante, G. Candiano, F. Perfumo, and G. M. Ghiggeri Serum Glomerular Permeability Activity in Patients with Podocin Mutations (NPHS2) and Steroid-ResistantNephrotic Syndrome J. Am. Soc. Nephrol., July 1, 2002; 13(7): 1946 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Koziell, V. Grech, S. Hussain, G. Lee, U. Lenkkeri, K. Tryggvason, and P. Scambler Genotype/phenotype correlations of NPHS1 and NPHS2 mutations in nephrotic syndrome advocate a functional inter-relationship in glomerular filtration Hum. Mol. Genet., February 1, 2002; 11(4): 379 - 388. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
